| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2008 | CA2659875A1 Multifunctional bioactive compounds |
| 02/07/2008 | CA2659874A1 Methods for the treatment of radiation proctosigmoiditis |
| 02/07/2008 | CA2659861A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologicdisorders |
| 02/07/2008 | CA2659835A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 02/07/2008 | CA2659800A1 Polycyclic dianthraquinones as inhibitors of inflammatory cytokines |
| 02/07/2008 | CA2659747A1 Non-flushing niacin analogues, and methods of use thereof |
| 02/07/2008 | CA2659746A1 Aryl vinyl sulfides, sulfones, sulfoxides and sulfonamides, derivatives thereof and therapeutic uses thereof |
| 02/07/2008 | CA2659733A1 Sterilized topical compositions of 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine |
| 02/07/2008 | CA2659712A1 Rho/rock/p13/akt kinase inhibitors for the treatment of diseases associated with protozoan parasites |
| 02/07/2008 | CA2659696A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 02/07/2008 | CA2659693A1 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors |
| 02/07/2008 | CA2659689A1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 02/07/2008 | CA2659687A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | CA2659684A1 Medicament for lct poisoning |
| 02/07/2008 | CA2659581A1 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 02/07/2008 | CA2659542A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | CA2659539A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 02/07/2008 | CA2659537A1 Methods and compositions for promoting activity of anti-cancer therapies |
| 02/07/2008 | CA2659511A1 Anticonvulsive pharmaceutical compositions |
| 02/07/2008 | CA2659477A1 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy |
| 02/07/2008 | CA2659473A1 Chemical compounds |
| 02/07/2008 | CA2659463A1 Combination therapy |
| 02/07/2008 | CA2659435A1 Combination andolast/glucocorticoids |
| 02/07/2008 | CA2659412A1 Urotensin ii receptor antagonists |
| 02/07/2008 | CA2659376A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | CA2659344A1 Treatment and prevention of excessive scarring |
| 02/07/2008 | CA2659336A1 Certain 1h-imidazo[4,5-b]pyrazin-2(3h)-ones and 1h-imidazo[4,5-b]pyrazin-2-ols, compositions thereof and their use |
| 02/07/2008 | CA2659161A1 Treatment of endocrine dysfunction using iron chelators |
| 02/07/2008 | CA2659148A1 Induction of analgesia in neuropathic pain |
| 02/07/2008 | CA2659122A1 Granule and orally disintegrating tablet comprising oxycodone |
| 02/07/2008 | CA2658911A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 02/07/2008 | CA2658799A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | CA2658797A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 02/07/2008 | CA2658793A1 Quinoline derivatives |
| 02/07/2008 | CA2658552A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | CA2658547A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | CA2658525A1 Smac peptidomimetics useful as iap inhibitors |
| 02/07/2008 | CA2658479A1 Novel hiv reverse transcriptase inhibitors |
| 02/07/2008 | CA2658446A1 Antiviral use of cationic surfactant |
| 02/07/2008 | CA2658340A1 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 02/07/2008 | CA2658313A1 Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives |
| 02/07/2008 | CA2658282A1 1h-indol-6-yl-piperazin-1-yl-methanone-derivatives for use as h3 receptor modulators |
| 02/07/2008 | CA2658279A1 Use of escin |
| 02/07/2008 | CA2657394A1 Preparation containing fibrate agent and process for producing the same |
| 02/07/2008 | CA2657342A1 Atp-sensitive potassium channel ligand, selected from sulfamides and glinides, or any combination thereof and methods for treating diabetes and neuropsychological dysfunction |
| 02/07/2008 | CA2657120A1 Soluble epoxide hydrolase inhibitors |
| 02/07/2008 | CA2656887A1 Antitumor combinations containing taxane derivatives |
| 02/07/2008 | CA2655682A1 Delayed-release glucocorticoid treatment of rheumatoid disease |
| 02/07/2008 | CA2652220A1 Adhesive preparation comprising methyl salicylate for percutaneous absorption |
| 02/07/2008 | CA2649044A1 Benzylphenyl glucopyranoside derivative |
| 02/07/2008 | CA2596153A1 Rimonabant-containing pharmaceutical preparation |
| 02/06/2008 | EP1884569A1 Sensitization of cancer cells to therapy using siNA targeting genes from the 1p and 19q chromosomal regions |
| 02/06/2008 | EP1884523A1 Biomarkers for polo-like kinase 1 activity |
| 02/06/2008 | EP1884516A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/06/2008 | EP1884515A1 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 02/06/2008 | EP1884514A1 Method for the resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazol and intermediate compounds |
| 02/06/2008 | EP1884513A1 Pyrazole compound and therapeutic agent for diabetes comprising the same |
| 02/06/2008 | EP1884510A1 N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same |
| 02/06/2008 | EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation |
| 02/06/2008 | EP1884245A1 Use of Escin |
| 02/06/2008 | EP1884244A1 Potassium channel ligands for treating diabetes and neuropsychological dysfunction |
| 02/06/2008 | EP1884243A1 Use of an antipsychotic drug for the treatment of ALS-associated cachexia |
| 02/06/2008 | EP1884242A1 Pharmaceutical composition |
| 02/06/2008 | EP1884241A1 A oral preparation comprising dyclonine hydrochloride |
| 02/06/2008 | EP1884240A1 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 02/06/2008 | EP1884239A1 Annellated pyrrole compounds for cancer management |
| 02/06/2008 | EP1884238A1 Agent having antiobesity activity and method of inhibiting obesity |
| 02/06/2008 | EP1884237A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 02/06/2008 | EP1884236A1 Angiogenesis inhibitor containing amine derivative as active ingredient |
| 02/06/2008 | EP1884235A1 Myeloerythroid progenitor differentiation inducer |
| 02/06/2008 | EP1884234A1 Prophylactic or therapeutic agent for corneal and conjunctival disorder |
| 02/06/2008 | EP1883708A1 Genemap of the human genes associated with crohn's disease |
| 02/06/2008 | EP1883647A1 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm |
| 02/06/2008 | EP1883646A1 A1 adenosine receptor agonists |
| 02/06/2008 | EP1883645A1 Derivatives of 4-or 5-aminosalicylic acid |
| 02/06/2008 | EP1883644A2 Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof |
| 02/06/2008 | EP1883638A1 Pyrrolo [2,3-d] imidazoles for the treatment of hyperproliferative disorders |
| 02/06/2008 | EP1883637A2 Non-nucleotide composition and method for inhibiting platelet aggregation |
| 02/06/2008 | EP1883636A1 Substituted piperidine antagonist of hi receptor to be used for the treatment of rhinitis |
| 02/06/2008 | EP1883633A2 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 02/06/2008 | EP1883632A1 Vanilloid receptor ligands and their use in treatments |
| 02/06/2008 | EP1883631A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof |
| 02/06/2008 | EP1883629A2 Novel heterocyclic derivatives |
| 02/06/2008 | EP1883627A1 Bir domain binding compounds |
| 02/06/2008 | EP1883626A2 LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1alpha,25-DIHYDROXY VITAMIN D3 |
| 02/06/2008 | EP1883625A2 Amorphous cinacalcet hydrochloride and preparation thereof |
| 02/06/2008 | EP1883624A1 D-homoandrosta-17-yl-carbamate derivatives as selective glucocorticoid receptor ligands |
| 02/06/2008 | EP1883620A1 ß-AMINO ACID DERIVATIVES |
| 02/06/2008 | EP1883614A2 Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/06/2008 | EP1883452A2 Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone |
| 02/06/2008 | EP1883451A2 Substituted indole compounds having nos inhibitory activity |
| 02/06/2008 | EP1883418A2 Sclerostin and the inhibition of wnt signaling and bone formation |
| 02/06/2008 | EP1883416A2 Compositions and methods for the prevention and treatment of conditions associated with inflammation |
| 02/06/2008 | EP1883413A2 Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer |
| 02/06/2008 | EP1883412A1 Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy |
| 02/06/2008 | EP1883411A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm |
| 02/06/2008 | EP1883410A2 Antibody or antibody fragment coupled with an immunogenic agent |
| 02/06/2008 | EP1883409A2 Phospholipids for use in the treatment of an allergic inflammatory condition |
| 02/06/2008 | EP1883408A2 Solid compositions and methods for treating middle-of-the night insomnia |
| 02/06/2008 | EP1883407A1 Compositions and methods for treatment for neoplasms |